HbA1c 0 5 0 5 B-clinical_variable
> 6 7 6 7 O
7.0 7 10 7 10 B-lower_bound
% 10 11 10 11 I-lower_bound
and 12 15 12 15 O
< 16 17 16 17 O
10.0 17 21 17 21 B-upper_bound
% 21 22 21 22 I-upper_bound

Individuals 0 11 23 34 O
with 12 16 35 39 O
evidence 17 25 40 48 O
of 26 28 49 51 O
proliferative 29 42 52 65 B-chronic_disease
diabetic 43 51 66 74 I-chronic_disease
retinopathy 52 63 75 86 I-chronic_disease
, 63 64 86 87 O
plasma 65 71 88 94 B-clinical_variable
creatinine 72 82 95 105 I-clinical_variable
> 83 84 106 107 O
1.4 84 87 107 110 B-lower_bound
females 88 95 111 118 B-gender
or 96 98 119 121 O
> 99 100 122 123 O
1.5 100 103 123 126 B-lower_bound
males 104 109 127 132 O
, 109 110 132 133 O
or 111 113 134 136 O
24 114 116 137 139 B-clinical_variable
- 116 117 139 140 I-clinical_variable
hour 117 121 140 144 I-clinical_variable
urine 122 127 145 150 I-clinical_variable
albumin 128 135 151 158 I-clinical_variable
excretion 136 145 159 168 I-clinical_variable
> 146 147 169 170 O
300 148 151 171 174 B-lower_bound
mg 152 154 175 177 I-lower_bound
will 155 159 178 182 O
be 160 162 183 185 O
excluded 163 171 186 194 O

Only 0 4 195 199 O
subjects 5 13 200 208 O
whose 14 19 209 214 O
body 20 24 215 219 B-clinical_variable
weight 25 31 220 226 I-clinical_variable
has 32 35 227 230 O
been 36 40 231 235 O
stable 41 47 236 242 O
( 48 49 243 244 O
Â± 49 50 244 245 O
3 51 52 246 247 B-lower_bound
lbs 53 56 248 251 I-lower_bound
) 56 57 251 252 O
over 58 62 253 257 O
the 63 66 258 261 O
preceding 67 76 262 271 B-upper_bound
three 77 82 272 277 I-upper_bound
months 83 89 278 284 I-upper_bound

